ライフサイエンスコーパス: marrow aspirate

1 of diagnosis who had detectable DTCs on bone marrow aspirate.

2 icroscopic analysis of blood smears and bone marrow aspirates.

3 nalyze peripheral-blood lymphocytes and bone marrow aspirates.

4 as tested on four human and four canine bone marrow aspirates.

5 dependent on morphologic examination of bone marrow aspirates.

6 tokeratin assay in preoperatively taken bone marrow aspirates.

7 a and fused with myeloma cells obtained from marrow aspirates.

8 or their DNA in spleen, lymph node, or bone marrow aspirates.

9 lymphoma cells mixed with normal human bone marrow aspirates.

10 t cells that can be easily derived from bone marrow aspirates.

11 s been applied to the in vitro study of bone marrow aspirates.

12 rred by 21-28 months in a second iliac crest marrow aspirate 1 year after the first aspirate in the D

13 R1 (n = 183) or CR2 (n = 70) who had pre-HCT marrow aspirates analyzed by 10-color flow cytometry.

14 t rigorous staging as defined by both a bone marrow aspirate and biopsy and an imaging study (a compu

15 Bone marrow aspirate and biopsy and bone scan are unnecessary

16 A marrow aspirate and biopsy revealed normal trilineage he

17 Bone marrow aspirate and biopsy specimens were studied, and p

18 ents had less than 10% total plasma cells on marrow aspirate and biopsy.

19 Sensitivity was comparable between marrow aspirate and biopsy.

20 A bone marrow aspirate and peripheral blood were obtained for m

21 therefore, peripheral blood smears and bone marrow aspirates and biopsies from 87 patients (143 tota

22 Unilateral iliac crest marrow aspirates and biopsies were performed on all pati

23 We reviewed bone marrow aspirates and biopsies, quantified blood/marrow c

24 leukemia cells mixed with normal human bone marrow aspirates and can also identify cancer cells clos

25 e of lymphoblasts from day 7 and day 14 bone marrow aspirates and more prolonged asparaginase activit

26 Using mouse and human bone marrow aspirates and mouse models challenged with highly

27 d cellular immune assays of iliac crest bone marrow aspirates and peripheral blood have begun to be c

28 Bone marrow aspirates and peripheral blood were obtained betw

29 Primary human MSC were cultured from bone marrow aspirates and then passaged at least three times

30 isolated from white adipose tissue and bone marrow aspirates and were s.c. implanted into immunodefi

31 eripheral blood and <1000 copies in the bone marrow aspirate), and high levels of MRD had an estimate

32 Our data demonstrate that serum, urine, marrow aspirate, and myeloblast 2-HG levels are signific

33 croscopy by 10-fold in samples of fresh bone marrow aspirate approximating minimal residual disease.

34 We collected bone marrow aspirates, archival bone marrow samples, and bloo

35 w measurements of recipient iliac crest bone marrow aspirates as in previous studies on peripheral bl

36 Among the seven centers, all used marrow aspirates as the starting material, but no two ce

37 MRD was assessed from first-pull bone marrow aspirates at baseline and annually by flow cytome

38 blood films (AUC 0.94 +/- 0.04) and in bone marrow aspirates (AUC 0.99 +/- 0.01).

39 c flow cytometry (MFC) was performed on bone marrow aspirates before HCT.

40 ession and chromatin landscape of human bone marrow, aspirated before and 90 days after BCG vaccinati

41 Peripheral-blood (PB) and/or bone marrow aspirate (BM) samples were obtained from 28 patie

42 f PC obtained prospectively from random bone marrow aspirates (BM) and paired imaging-guided biopsies

43 Cytomorphological analysis of the bone marrow aspirate (BMA) is pivotal for the diagnostic work

44 icroscopy inspection of blood films and bone marrow aspirates by a hematologist is a crucial step in

45 In primary myeloma cells derived from bone marrow aspirates, CD46-ADC induced apoptosis and cell de

46 Bone marrow aspirate concentrate (BMAC) and adipose-derived s

47 ered ACL matrix by supplementation with bone marrow aspirate concentrate (BMAC) and growth factors (B

48 aluation of a subset of patient-derived bone marrow aspirate concentrate (BMAC) samples used in a pha

49 Arm 1: autologous bone marrow aspirate concentrate (n = 120), CSI (n = 40); arm

50 apies (such as platelet-rich plasma and bone marrow aspirate concentrate) is common, high-quality cli

51 cacy of cell injections from autologous bone marrow aspirate concentrate, autologous adipose stromal

52 Moreover, iliac crest bone marrow aspirates contained an average of thirteen times

53 nd mesenchymal cells derived from human bone marrow aspirates express the cell-bound form of fractalk

54 ral blood mononuclear cells (PBMCs) and bone marrow aspirates for regulatory T cells (Tregs) (e.g., C

55 bulin FISH done on cytospin slides from bone marrow aspirates for t(11;14), t(4;14), and -17(p13.1) (

56 ng, to identify mutations in samples of bone marrow aspirate from 439 patients with myelodysplastic s

57 rom a mean +/- SD of 23.4 +/- 5.9 mL of bone marrow aspirate from all patients.

58 ositivity for MMc was demonstrated in a bone marrow aspirate from an SSc patient in whom peripheral b

59 We obtained bone marrow aspirates from 11 patients on ART who had undetec

60 frequency of S-specific plasma cells in bone marrow aspirates from 18 individuals who had recovered f

61 , cytokine mRNA levels were measured in bone marrow aspirates from 27 naturally infected dogs from Br

62 Here, we analyzed bone marrow aspirates from 44 advanced prostate cancer patien

63 (ISH) for IL-1beta was performed using bone marrow aspirates from 51 MM, 7 smoldering MM, 21 MGUS, a

64 Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abund

65 icroscopic levels of leukaemic cells in bone-marrow aspirates from children with acute lymphoblastic

66 presence of disseminated tumor cells in bone marrow aspirates from early stage breast cancer patients

67 itro differentiated CD34 cells and from bone marrow aspirates from Fy-negative samples express a func

68 nique, we analyzed peripheral blood and bone marrow aspirates from human clinical samples, and identi

69 tency, these transcripts are present in bone marrow aspirates from naturally infected, healthy seropo

70 ocedure, the extent of demethylation in bone marrow aspirates from patients with leukemia receiving d

71 Bone marrow aspirates from the patient showed <0.1% CD19(+) B

72 Repeated analyses of blood and bone marrow aspirates gave no indication of hematopoietic dis

73 In the DBMC group, chimerism in iliac crest marrow aspirates has increased 3-fold in yearly sequenti

74 er for magnetic separation of CTPs from bone marrow aspirates in a canine model.

75 color multiparametric flow cytometry on bone marrow aspirates in all patients.

76 Bone marrow aspirates in two patients had markedly decreased

77 otyping to profile 38,410 cells from 40 bone marrow aspirates, including 16 AML patients and five hea

78 Potential admixture of blood with bone marrow aspirate limits our ability to determine the orig

79 tion of transplantable tissues in which bone marrow aspirates may serve as an accessible source of au

80 ized to receive autologous concentrated bone marrow aspirate (n = 10; 3 x 10(6) white blood cells and

81 Bone marrow aspirates (n = 629) were collected at the end of

82 Ten normal bone marrow aspirates (NBM) were first analyzed using an eryt

83 One bone marrow aspirate obtained before treatment, one whole blo

84 id cells subsequently detected in sequential marrow aspirates obtained from 2 primary NOD/SCID-IL2Rga

85 CD70 in the CD10(+)/CD19(+) fraction of bone marrow aspirates obtained from relapsed compared with no

86 MSCs were prepared from bone marrow aspirates obtained from the iliac crest or from t

87 Single-cell RNA-sequencing performed in bone marrow aspirates of 11 MM patients and 8 healthy donors

88 ells isolated by CD138 sorting from the bone marrow aspirates of 6 patients.

89 levels of serglycin are present in the bone marrow aspirates of at least 30% of newly diagnosed MM p

90 ected by a rapid immunological assay in bone-marrow aspirates of children with ALL.

91 ropagation and function of MSCs derived from marrow aspirates of CLL patients in vitro.

92 ygen on the growth and function of MSCs from marrow aspirates of CLL patients.

93 Moreover, cells isolated from bone marrow aspirates of patients in different stages of CML

94 20) that can typically be obtained from bone marrow aspirates of prostate-cancer patients.

95 cies of mature B cells were observed in bone marrow aspirates of these individuals compared with HIV-

96 an mesenchymal stem cells were isolated from marrow aspirates of volunteer donors.

97 urden cohorts (HTBC or LTBC) based on a bone marrow aspirate or biopsy before infusion.

98 f hematopoietic stem cells from a human bone marrow aspirate possessing only 4000 total cells.

99 ce of platelet-rich plasma derived from bone marrow aspirate (PRP-BMA) on the healing of periodontal

100 testing of whole blood, buffy coat, and bone marrow aspirates, respectively.

101 Cytologic analysis of bone marrow aspirates revealed a striking enhancement of mono

102 mon VEXAS syndrome is in patients whose bone marrow aspirates show this distinctive feature, finding

103 etails of the individual cases reviewed bone marrow aspirate slides to determine plasmablastic classi

104 Bone marrow aspirate smears and biopsies may show reactive hi

105 Blood and bone marrow aspirate testosterone concentrations declined to

106 n >/= 10% was correlated with increased bone marrow aspirate testosterone.

107 uncomplicated typhoid and satisfactory bone marrow aspirates, the number of serovar Typhi CFU in bon

108 ssion of testosterone in both blood and bone marrow aspirate to less than picograms-per-milliliter le

109 tained from peripheral blood or through bone marrow aspirates, together with recent advances in cance

110 ng (WGS) was performed on the patient's bone marrow aspirate, using an Illumina NextSeq500 platform.

111 A small bone marrow aspirate was taken from the iliac crest of health

112 tes, the number of serovar Typhi CFU in bone marrow aspirates was a median value of 9 (interquartile

113 roduction by CD138+ cells enriched from bone marrow aspirates was abrogated.

114 utologous granulocytic progenitors from bone marrow aspirate were performed in two patients with unex

115 Bone marrow aspirates were analyzed for their neutrophil diff

116 Bone-marrow aspirates were collected after induction therapy

117 Results of studies in bilateral marrow aspirates were highly concordant.

118 Blood and bone marrow aspirates were obtained from 4 patients (2 unrela

119 Bone marrow aspirates were performed at baseline for explorat

120 Bone marrow aspirates were stained with the pancytokeratin ma

121 Bone marrow aspirates were subject to a negative-selection pr

122 rations of PDGF-AA and PDGF-BB found in bone marrow aspirates, which were detected by ELISA, do not a

123 A bone-marrow aspirate with biopsy was performed, yielding the